Paying users zone. Data is covered by 
.
Get to Biogen Inc. for $17.99, or
get to entire website for at least 3 months from $49.99.
Income Statement
Quarterly Data
Difficulty: Beginner
The income statement presents information on the financial results of a company's business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Biogen Inc., Consolidated Income Statement (quarterly data)
USD $ in thousands
Based on: 10-Q (filing date: 2018-10-23), 10-Q (filing date: 2018-07-24), 10-Q (filing date: 2018-04-24), 10-K (filing date: 2018-02-01), 10-Q (filing date: 2017-10-24), 10-Q (filing date: 2017-07-25), 10-Q (filing date: 2017-04-25), 10-K (filing date: 2017-02-02), 10-Q (filing date: 2016-10-26), 10-Q (filing date: 2016-07-21), 10-Q (filing date: 2016-04-21), 10-K (filing date: 2016-02-03), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-24), 10-Q (filing date: 2015-04-24), 10-K (filing date: 2015-02-04), 10-Q (filing date: 2014-10-22), 10-Q (filing date: 2014-07-23), 10-Q (filing date: 2014-04-23), 10-K (filing date: 2014-02-06), 10-Q (filing date: 2013-10-28), 10-Q (filing date: 2013-07-25), 10-Q (filing date: 2013-04-25).
| Item | Description | The company |
|---|---|---|
| Revenues | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. | Biogen Inc.'s revenues increased from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018. |
| Income from operations | The net result for the period of deducting operating expenses from operating revenues. | Biogen Inc.'s income from operations declined from Q1 2018 to Q2 2018 but then increased from Q2 2018 to Q3 2018 exceeding Q1 2018 level. |
| Income before income tax expense and equity in loss of investee, net of tax | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Biogen Inc.'s income before income tax expense and equity in loss of investee, net of tax declined from Q1 2018 to Q2 2018 but then increased from Q2 2018 to Q3 2018 exceeding Q1 2018 level. |
| Net income attributable to Biogen Inc. | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Biogen Inc.'s net income attributable to Biogen Inc. declined from Q1 2018 to Q2 2018 but then increased from Q2 2018 to Q3 2018 exceeding Q1 2018 level. |
